Collagen type IV and Collagen type VI (COL4/COL6)

Collagen type IV and Collagen type VI are fundamental structural proteins of the extracellular matrix (ECM) with distinct but complementary roles in tissue architecture. Collagen IV is the primary component of the basement membrane, forming a complex, non-fibrillar network that provides mechanical stability and acts as a selective permeability barrier, particularly in the renal glomerulus and blood-brain barrier [1][2]. Collagen VI is a microfibrillar collagen that serves as a critical mechanical link between the basement membrane and the surrounding interstitial matrix, ensuring the structural integrity of muscle fibers and skin [3][4]. Pathologically, the excessive deposition of these collagens is a hallmark of chronic fibrotic diseases of the liver, lungs, and kidneys, where they contribute to organ stiffness and dysfunction [5]. Genetic mutations in the genes encoding these proteins lead to severe hereditary conditions, including Alport syndrome (Collagen IV) and Bethlem myopathy or Ullrich congenital muscular dystrophy (Collagen VI) [6][7]. Therapeutic interventions aim to modulate their synthesis through anti-fibrotic drugs like Nintedanib or to address mitochondrial dysfunction associated with Collagen VI deficiencies using agents like Cyclosporin A [8][9]. Furthermore, specific fragments of these proteins, such as PRO-C4 and PRO-C6 (endotrophin), are widely used as non-invasive biomarkers to monitor fibrotic activity and predict patient outcomes in clinical trials [10].

Other names

Basement membrane collagenMicrofibrillar collagenCOL4ACOL6AEndotrophin

Inhibition of extracellular matrix synthesis, reduction of TGF-beta signaling, and stabilization of the mitochondrial permeability transition pore.